Kava drink tested to help smokers cut down and lower cancer risk
NCT ID NCT05081882
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a daily kava drink can help active smokers who don't plan to quit reduce their smoking and lower their risk of lung cancer. Twenty adult smokers will take kava daily for several months. Researchers will check how well participants stick with the regimen, and whether it leads to fewer cigarettes smoked and less cancer-related damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMOKING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Florida
Gainesville, Florida, 32608, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a child's doctor visit spark a parent's quit-smoking journey?
- Can sleep patterns explain racial gaps in smoking cravings?
- Brain training on your phone may curb cigarette cravings — a trial puts it to the test
- Smoking ban may shield Non-Smokers' blood vessels
- Heated tobacco devices tested as a tool to help smokers kick the habit
- New nicotine pouches put to the test: are they less addictive than cigarettes?